Evidence map›Paper›PMID 27537840›Full record

ArticlePloS one2016

Arid3b Is Critical for B Lymphocyte Development.

Jeffrey L Kurkewich, Nathan Klopfenstein, William M Hallas, Christian Wood, Rachel A Sattler, Chhaya Das, Haley Tucker, Richard Dahl, Karen D Cowden Dahl

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. RUNX1 and the endothelial origin of blood.Experimental hematology · 2018
    Review
  9. A Role for the Transcription FactorFrontiers in immunology · 2017
    Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jeffrey L KurkewichDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.
Nathan KlopfensteinHarper Cancer Research Institute, South Bend, Indiana, United States of America.
William M HallasHarper Cancer Research Institute, South Bend, Indiana, United States of America.
Christian WoodDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.
Rachel A SattlerHarper Cancer Research Institute, South Bend, Indiana, United States of America.
Chhaya DasInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
Haley TuckerInstitute for Cellular and Molecular Biology, Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, United States of America.
Richard DahlDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, United States of America.
Karen D Cowden DahlHarper Cancer Research Institute, South Bend, Indiana, United States of America.
Indiana University · USThe University of Texas at Austin · USUniversity of Notre Dame · USIndiana University School of MedicineMike and Josie Harper Cancer Research Institute

Funding

MAR MEDIATED GENETIC SWITCH FOR IGH ENHANCER CONTROLR01CA031534 · NCI · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI TUCKER, HALEY O · 1985 to 2012
$2.9M
NCI NIH HHS R01 CA031534
6 · The paper itself

Abstract

Arid3a and Arid3b belong to a subfamily of ARID (AT-rich interaction domain) transcription factors. The Arid family is involved in regulating chromatin accessibility, proliferation, and differentiation. Arid3a and Arid3b are closely related and share a unique REKLES domain that mediates their homo- and hetero-multimerization. Arid3a was originally isolated as a B cell transcription factor binding to the AT rich matrix attachment regions (MARS) of the immunoglobulin heavy chain intronic enhancer. Deletion of Arid3a results in a highly penetrant embryonic lethality with severe defects in erythropoiesis and hematopoietic stem cells (HSCs). The few surviving Arid3a-/- (<1%) animals have decreased HSCs and early progenitors in the bone marrow, but all mature lineages are normally represented in the bone marrow and periphery except for B cells. Arid3b-/- animals die around E7.5 precluding examination of hematopoietic development. So it is unclear whether the phenotype of Arid3a loss on hematopoiesis is dependent or independent of Arid3b. In this study we circumvented this limitation by also examining hematopoiesis in mice with a conditional allele of Arid3b. Bone marrow lacking Arid3b shows decreased common lymphoid progenitors (CLPs) and downstream B cell populations while the T cell and myeloid lineages are unchanged, reminiscent of the adult hematopoietic defect in Arid3a mice. Unlike Arid3a-/- mice, HSC populations are unperturbed in Arid3b-/- mice. This study demonstrates that HSC development is independent of Arid3b, whereas B cell development requires both Arid3a and Arid3b transcription factors.

Indexed as

AnimalsB-LymphocytesBone Marrow CellsCells, CulturedDNA-Binding ProteinsElectrophoretic Mobility Shift AssayFemaleFlow CytometryImmunoblottingImmunoprecipitationLuciferasesMaleMiceMice, Inbred C57BLMice, KnockoutReverse Transcriptase Polymerase Chain ReactionArid3b protein, mouseDNA-Binding ProteinsLuciferases

Identifiers

PMID27537840
PMCPMC4990195
OpenAlexW2517611341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.